Rashmi Kanagal-Shamanna, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the objectives of the Cancer Genomics Consortium (CGC), which include improving patient care and genetic classification. Dr Kanagal-Shamanna also shares her excitement for the upcoming August 2023 CGC meeting, which is now accepting abstracts. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.